Needham Downgrades Avidity Biosciences (RNA) to Hold Oct 27, 2025 07:05AM
Avidity Biosciences to Participate in Upcoming Investor Conference Apr 1, 2025 09:00AM
Avidity Biosciences Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Aug 19, 2024 09:00AM
Avidity Biosciences Inc. (RNA) Prices Upsized 7.32M Share Offering at $41/sh Aug 15, 2024 06:17AM
Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock Aug 14, 2024 08:30PM


Mar 27, 2024 09:00AM Avidity Biosciences to Participate in Upcoming Investor Conferences
Dec 16, 2022 05:49AM Avidity Biosciences (RNA) Prices Upsized 12M Share Offering at $17.25/sh
Dec 15, 2022 07:37PM Avidity Biosciences, Inc. Announces Pricing of Upsized Public Offering of Common Stock
Dec 15, 2022 07:00AM Avidity Biosciences Inc. (RNA) Announces Proposed $150M Share Offering
Dec 15, 2022 07:00AM Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock
Mar 2, 2022 06:46AM Needham & Company Reiterates Avidity Biosciences (RNA) at Buy
Feb 11, 2022 04:05PM Avidity Biosciences to Participate in Upcoming Investor Conferences
Jun 17, 2021 06:20AM UPDATE: Needham & Company Starts Avidity Biosciences (RNA) at Buy, $50 PT
Mar 25, 2021 04:05PM Avidity Biosciences to Participate in Upcoming Investor Conferences
Nov 24, 2014 09:31AM Pre-Open Stock Movers 11/24: (RNA) (CIMT) (PTP) Higher; (LGF) (TSL) (CBI) Lower (more...)
Jul 23, 2013 10:43AM Notable Analyst Rating Changes 07/23: (TSS) (BHI) (ABX) Upgraded; (QSII) (BNNY) (ISIS) Downgraded